Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

Abstract Introduction The purpose of this study was to investigate whether the inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has a similar effectiveness and safety profile in patients with rheumatic and musculoskeletal diseases (RMDs) and healthy controls (HCs). Me...

Full description

Bibliographic Details
Main Authors: Xiaowei Zhang, Yifei Li, Chunqing Dai, Yaya Chu, Chaoqi Luan, Guihong Wang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Rheumatology and Therapy
Subjects:
Rheumatic diseases
Musculoskeletal diseases
SARS-CoV-2 vaccine
Serum antibodies
Adverse events
Omicron variant
Online Access:https://doi.org/10.1007/s40744-023-00630-5

Internet

https://doi.org/10.1007/s40744-023-00630-5

Similar Items